產品
重要性是模型對已發布報導給出的 1–5 分,不是對市場的預測。
已排定事件列上的影響是公司顯著度層級(高/中由圖譜中心度與規模判定;低僅用於人工整理的次要事件),不是對波動幅度的預測。
標記為已確認的財報日期,是 Yahoo Finance 認定由公司確認的;預估表示尚未公布。未加標記的列沒有可查的出處記錄。
經濟數據發布屬於總體經濟、不歸屬任何產業,因此在任何檢視下都會保留。沒有數值的發布表示尚未公布,頁面會直說,而不是顯示為零。
涵蓋被追蹤公司的即將到來的事件;已過去的事件會歸檔,並在可得時補上結果——這些結果都經人工整理並附引用,絕不杜撰。沒有結果的歷史列會顯示「結果待定」。
閉鎖期屆滿或指數調整的列會多出一行算術——將變得可賣出的股數,或指數基金必須買進的股數,以佔流通股的比例表示——依招股說明書或指數編製方法讀出,兩個數字都在該列註明出處。它陳述的是機制,不是價格走勢。由 IPO + 180 天推算出的閉鎖期日期會一直標為預估,直到公司自己說明為止。
10月12日週一 · 今天
10月13日週二
9月11日週五
產品
合作
Intel Foundry and ASML said their joint High-NA EUV work has passed one million wafers processed and is moving the tool toward production readiness. Intel remains the lead customer proving out ASML's next-generation lithography.
財報
Oracle's earnings report disclosed AI cloud backlog (remaining performance obligations) of $664 billion, sending the stock up about 7%. Neocloud peers including CoreWeave rose roughly 4% on the read-through to AI infrastructure demand.
Investing Oracle Surges 7% as AI Cloud Backlog Hits $664B, CoreWeave and Nebius Climb 4% Oracle just posted a backlog figure large enough to reshape how the entire AI cloud infrastructure trade gets valued, and two GPU cloud pure-plays are already moving in sympathy before the broader market has fully processed what it means. By David Moadel Published September 11, 2026, 9:31am ET · 4 min read Market Movers desk. Editor: David Moadel . 𝕏 f ⧉ This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. © Sun…
融資
Eli Lilly closed its acquisition of AtaiBeckley, taking full ownership of the psychedelics-focused biotech after shareholders approved the merger earlier in the week. The deal adds a depression-treatment pipeline to Lilly's neuroscience portfolio.
產品
Moderna and Merck reported that their individualized mRNA cancer vaccine combined with Keytruda significantly improved survival in a phase 3 melanoma trial, the first late-stage win for a personalized mRNA cancer vaccine. Detailed trial data have not yet been presented at a medical meeting.